Literature DB >> 11938437

Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin).

Valérie Allamand1, Pascale Guicheney.   

Abstract

Congenital muscular dystrophies (CMDs) are a highly heterogeneous group of neuromuscular disorders. A subgroup displays a specific deficiency in a protein of the extracellular matrix, the alpha2 chain of laminin-2 (merosin). A number of mutations in the gene encoding this protein have been identified in patients who present with a severe phenotype and white matter changes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11938437     DOI: 10.1038/sj.ejhg.5200743

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  37 in total

1.  Child with Isolated Motor Delay: Look at the Neuroimage.

Authors:  Indar Kumar Sharawat; Ananthanarayanan Kasinathan; Naveen Sankhyan
Journal:  Indian J Pediatr       Date:  2018-05-22       Impact factor: 1.967

Review 2.  Laminin-211 in skeletal muscle function.

Authors:  Johan Holmberg; Madeleine Durbeej
Journal:  Cell Adh Migr       Date:  2012-11-15       Impact factor: 3.405

3.  Merosin-deficient congenital muscular dystrophy with cerebral white matter changes: a clue to its diagnosis beyond infancy.

Authors:  Sandeep Kumar; Shrikiran Aroor; Suneel Mundkur; Maneesh Kumar
Journal:  BMJ Case Rep       Date:  2014-03-06

4.  Laminin regulates postnatal oligodendrocyte production by promoting oligodendrocyte progenitor survival in the subventricular zone.

Authors:  Jenne Relucio; Michael J Menezes; Yuko Miyagoe-Suzuki; Shin'ichi Takeda; Holly Colognato
Journal:  Glia       Date:  2012-06-17       Impact factor: 7.452

5.  Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy.

Authors:  Mahasweta Girgenrath; Janice A Dominov; Christine A Kostek; Jeffrey Boone Miller
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

6.  Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin.

Authors:  Chunping Qiao; Jianbin Li; Tong Zhu; Romesh Draviam; Simon Watkins; Xiaojing Ye; Chunlian Chen; Juan Li; Xiao Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

7.  New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families.

Authors:  Nacim Louhichi; Chahnez Triki; Susana Quijano-Roy; Pascale Richard; Samira Makri; Mériem Méziou; Brigitte Estournet; Slah Mrad; Norma B Romero; Hammadi Ayadi; Pascale Guicheney; Faiza Fakhfakh
Journal:  Neurogenetics       Date:  2003-12-02       Impact factor: 2.660

8.  Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle.

Authors:  Bruno Menezes de Oliveira; Cintia Y Matsumura; Cibely C Fontes-Oliveira; Kinga I Gawlik; Helena Acosta; Patrik Wernhoff; Madeleine Durbeej
Journal:  Mol Cell Proteomics       Date:  2014-07-03       Impact factor: 5.911

9.  Ku70 regulates Bax-mediated pathogenesis in laminin-alpha2-deficient human muscle cells and mouse models of congenital muscular dystrophy.

Authors:  Vivek K Vishnudas; Jeffrey Boone Miller
Journal:  Hum Mol Genet       Date:  2009-08-19       Impact factor: 6.150

10.  Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy.

Authors:  Mahasweta Girgenrath; Mary Lou Beermann; Vivek K Vishnudas; Sachiko Homma; Jeffrey Boone Miller
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.